Actieve functies van Elisa Kieback
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Oprichter | 01-01-2018 | - |
| Hoofd Techniek/Wetenschap/O&O | 19-01-2021 | - | |
| Algemeen Directeur | 01-01-2018 | 19-01-2021 |
Loopbaan van Elisa Kieback
Statistieken
Internationaal
| Duitsland | 2 |
Operationeel
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Health Technology |
- Beurs
- Insiders
- Elisa Kieback
- Ervaring
